Sponsor Articles

Mirriam Monge, Sartorius Stedim Biotech As current biological product pipelines become more diverse, product demands are varied while there is an increased pressure to keep cost of development and production down. To meet these demands, Bio-pharma innovators and CDMOs are evaluating the implementation of process intensification...

Gerard Gach, Chief Marketing Officer at YMC Process Technologies Continuous manufacturing in bioprocessing is moving out of the lab and into production suites at an accelerated pace. An ever-increasing capacity in the production of mAbs, peptides, oligo and other biologics are leveraging some form of continuous...

Dave Anderson, Director of Sales and Marketing at Aber Instruments Ltd ABER continue to develop key solutions for bioprocessing and look forward to showcasing some of these developments with you over the course of World Biopharm Forum 2021 The biopharmaceutical industry relies on proven online analytics to...